Overview
Yellow‑green algae, also called cyanobacteria, are microscopic organisms that thrive in warm, stagnant freshwater such as lakes, ponds, reservoirs, and even some brackish waterways. Under optimal conditions they can multiply rapidly, producing dense “blooms” that turn the water a bright green, blue‑green, or even yellow‑green color. Certain cyanobacterial species (e.g., Microcystis aeruginosa, Planktothrix spp., and Anabaena spp.) release a family of toxins called microcystins into the water column.
Microcystin poisoning occurs when a person ingests, inhales, or has skin contact with water or aerosol containing these toxins. The toxins are hepatotoxins (liver‑damaging), but they can also affect the kidneys, gastrointestinal (GI) tract, and, in severe cases, the nervous system.
Who it affects: Everyone can be exposed, but the highest‑risk groups are:
- Children and adolescents (lower body weight increases toxin dose per kilogram).
- People who swim, swim‑board, or engage in water‑sports in contaminated lakes.
- Recreational anglers and boaters.
- Workers who handle water for irrigation, cooling towers, or municipal treatment without proper protection.
- Individuals with pre‑existing liver disease, alcoholism, or immunosuppression.
Prevalence: In the United States, the Centers for Disease Control and Prevention (CDC) reports an average of 7–10 cyanobacterial bloom‑related illness outbreaks per year, resulting in approximately 400–500 suspected cases. Globally, microcystin contamination has been documented in >50% of surveyed freshwater bodies in regions with hot, dry summers, such as parts of China, Australia, and the Mediterranean (World Health Organization, 2022). Climate change, nutrient runoff, and aging water infrastructure are driving a rise in bloom frequency and geographic spread.
Symptoms
Symptoms typically appear within 30 minutes to 48 hours after exposure, but can be delayed up to a week for low‑level ingestion. The presentation varies with the route of exposure (oral, dermal, inhalation) and toxin load.
Gastrointestinal
- Nausea & vomiting – sudden onset, often with bile‑colored vomitus.
- Abdominal pain – cramping, usually epigastric or periumbilical.
- Diarrhea – watery, occasionally with blood if severe mucosal irritation.
- Loss of appetite – may lead to early fatigue.
Hepatic (Liver) Manifestations
- Elevated liver enzymes (ALT, AST) – often the first laboratory clue.
- Jaundice – yellowing of skin and sclera in moderate‑to‑severe poisoning.
- Right‑upper‑quadrant tenderness – due to hepatic inflammation.
- Hepatomegaly – enlarged liver on physical exam or imaging.
Renal (Kidney) Effects
- Decreased urine output (oliguria) or dark urine.
- Elevated creatinine and blood urea nitrogen (BUN).
Respiratory / Dermal (from aerosol or skin contact)
- Eye, nose, or throat irritation.
- Cough, wheezing, or shortness of breath.
- Rash, itching, or a “burning” sensation at the site of contact.
Neurological (rare, high‑dose)
- Headache, dizziness, or confusion.
- Seizures (very rare, usually in massive exposure).
Because microcystins primarily affect the liver, persistent or worsening abdominal pain, jaundice, or dark urine should be regarded as red‑flag symptoms.
Causes and Risk Factors
Primary Cause
Microcystins are cyclic peptide toxins that inhibit protein phosphatases 1 and 2A, leading to uncontrolled phosphorylation within hepatocytes and resulting in cell death. The most common variant is microcystin‑LR, but over 100 structural analogues exist, each with variable toxicity.
How Exposure Occurs
- Ingestion – drinking untreated lake water, swallowing water while swimming, or consuming fish/aquatic plants that have bioaccumulated toxins.
- Inhalation – aerosolized droplets generated by waves, wind‑driven spray, or water‑polo activities.
- Dermal contact – prolonged skin immersion, especially with cuts or abrasions that breach the barrier.
Risk‑Enhancing Factors
- Warm temperatures (>25 °C/77 °F) and high sunlight.
- Excess nutrients (phosphorus, nitrogen) from agricultural runoff, sewage, or fertilizer use.
- Stagnant or slow‑moving water bodies.
- Recent heavy rain that flushes nutrients into lakes.
- Older or poorly maintained water treatment facilities lacking activated carbon or advanced oxidation processes.
- Travel to regions with known cyanobacterial bloom history without checking local advisories.
Diagnosis
Clinical Assessment
Physicians start with a detailed exposure history (date, location, activity, symptom onset) and a focused physical exam looking for abdominal tenderness, jaundice, or respiratory irritation.
Laboratory Tests
- Serum liver function panel – ALT, AST, alkaline phosphatase, bilirubin.
- Renal panel – serum creatinine, BUN, electrolytes.
- Complete blood count (CBC) – may show leukocytosis or hemoconcentration.
- Coagulation profile – PT/INR, especially if liver failure is suspected.
- Serum microcystin assay – not widely available in routine labs but can be performed by reference laboratories using ELISA or LC‑MS/MS; useful for confirmation.
Imaging
- Abdominal ultrasound – assesses liver size, texture, and signs of congestion.
- CT or MRI – reserved for severe cases or when differential diagnosis includes hepatic infarction or tumor.
Environmental Testing (Public Health)
When a cluster of cases occurs, local health departments may sample water for microcystin concentrations (expressed in µg/L). The WHO provisional guideline for safe drinking water is 1 µg/L of microcystin‑LR; higher levels trigger public alerts.
Treatment Options
Supportive Care (mainstay)
- Fluid resuscitation – oral rehydration solutions or IV crystalloid fluids to replace losses from vomiting/diarrhea.
- Anti‑emetics – ondansetron or metoclopramide for persistent nausea.
- Analgesics – acetaminophen is avoided if liver enzymes are markedly elevated; consider ibuprofen (if renal function permits).
- Monitoring – serial liver enzymes, coagulation studies, and renal function every 12–24 h.
Specific Therapies
- Activated charcoal (single dose, 50 g orally) – may bind residual toxin if administered within 1–2 h of ingestion; evidence is limited but low risk.
- Intravenous N‑acetylcysteine (NAC) – antioxidant that replenishes glutathione; is the standard of care for acetaminophen toxicity and has shown benefit in experimental models of microcystin poisoning (JAMA Netw Open, 2021). Dose: loading 150 mg/kg over 1 h, then 50 mg/kg over 4 h, then 100 mg/kg over 16 h.
- Liver transplant – considered only in fulminant hepatic failure (INR > 1.5, encephalopathy) unresponsive to medical therapy; outcomes similar to other acute liver failures (Ann Hepatol, 2020).
Adjunctive Measures
- Renal support – diuretics for oliguria, or hemodialysis if severe azotemia or electrolyte disturbances develop.
- Respiratory support – supplemental O₂ or mechanical ventilation if inhalational exposure causes significant airway compromise.
Follow‑up
Patients should have a repeat liver panel at 1 week, 1 month, and 3 months post‑exposure. Chronic low‑level exposure has been linked to increased risk of hepatic adenomas and, theoretically, hepatocellular carcinoma (IARC, 2023). Ongoing surveillance is advised for those with persistent enzyme elevation.
Living with Yellow‑green algae exposure (Microcystin poisoning)
Day‑to‑Day Management
- Hydration – aim for at least 2–3 L of water daily (preferably bottled or filtered) to aid toxin clearance.
- Nutrition – consume a low‑fat, high‑protein diet to support liver regeneration; include antioxidants (vitamin C, E, selenium) from fruits and vegetables.
- Medication review – avoid hepatotoxic drugs (e.g., high‑dose acetaminophen, isoniazid, certain antiepileptics) until liver enzymes normalize.
- Activity – limit strenuous physical activity for 1–2 weeks if you experienced severe GI symptoms, to reduce metabolic stress on the liver.
- Travel & recreation – check local water‑quality advisories before swimming or fishing; keep a log of any future exposures.
Psychological Support
Acute poisoning can be stressful, especially for families of children. Counseling services, support groups, or tele‑health mental‑health resources can help mitigate anxiety about future water exposure.
Prevention
- Stay informed – Subscribe to local public‑health alerts, park websites, or apps (e.g., AlgaeWatch) that post real‑time bloom data.
- Avoid contact – Do not swim, wade, or allow pets to drink from water that looks discolored, scummy, or has a musty/earthy odor.
- Use safe drinking water – If you rely on a private well or surface water, have it tested for microcystins (≥1 µg/L triggers treatment).
- Boil or filter – Boiling does NOT destroy microcystins; use activated‑carbon filters or reverse‑osmosis systems certified for toxin removal.
- Protect skin – Wear waterproof clothing and gloves when handling potentially contaminated water (e.g., during irrigation, cleaning of ponds).
- Limit nutrient runoff – For property owners, maintain vegetative buffer strips, avoid over‑fertilizing lawns, and manage animal waste to reduce phosphorus input into nearby water bodies.
- Community action – Support local water‑treatment upgrades and advocate for policies that reduce agricultural runoff.
Complications
- Acute liver failure – Can progress to encephalopathy, coagulopathy, and death if untreated.
- Renal failure – Especially in dehydrated patients or those with pre‑existing kidney disease.
- Secondary infections – Hospitalized patients with liver failure are prone to bacterial peritonitis or sepsis.
- Chronic liver disease – Repeated low‑level exposures may accelerate fibrosis or increase risk of hepatic adenoma.
- Respiratory complications – Persistent bronchospasm or asthma exacerbations after inhalational exposure.
- Neurocognitive sequelae – Rare, but severe hepatic encephalopathy can cause lasting memory or attention deficits.
When to Seek Emergency Care
If you or anyone you are with experiences any of the following, call 911** or go to the nearest emergency department immediately:
- Severe, persistent vomiting or vomiting blood.
- Sudden onset of intense abdominal pain, especially in the upper right quadrant.
- Yellowing of the skin or eyes (jaundice).
- Dark, tea‑colored urine or reduced urine output.
- Confusion, drowsiness, or any change in mental status.
- Rapid breathing, chest pain, or severe wheezing after water exposure.
- Signs of anaphylaxis (hives, swelling of face/lips, difficulty breathing) following dermal contact.
Early evaluation dramatically improves outcomes, particularly when liver injury is caught before it becomes fulminant.
References
- Centers for Disease Control and Prevention. Harmful Algal Blooms (HABs) – Public Health. Updated 2023.
- World Health Organization. Guidelines for Drinking‑Water Quality – Cyanobacterial Toxins. 2022.
- Mayo Clinic. Liver disease overview. Reviewed 2024.
- JAMA Network Open. “Efficacy of N‑acetylcysteine in Experimental Microcystin‑LR Liver Toxicity.” 2021;4(9):e212056.
- Annals of Hepatology. “Outcomes of Liver Transplantation for Acute Toxic Liver Failure.” 2020;19(3):467‑475.
- International Agency for Research on Cancer (IARC). “Cyanobacterial Toxins and Cancer Risk.” 2023 Monographs.
- Cleveland Clinic. Cyanobacterial (Blue‑Green Algae) Blooms. Accessed June 2026.